// App-Quantinova.ai

BSH2020‐PO‐010 : Combination therapies targeting apoptosis pathways in paediatric AML

Researchers

Presenter

  • A. Ali

Principal Investigators

  • K. Lappin

  • J. Blayney

  • K. Mills

Medical Centers

  • Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

  • Solid malignancies

Biomarkers

  • B-cell lymphoma 2

  • Breakpoint Cluster Region

  • Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform

  • C-X-C motif chemokine ligand 9

Drug/Treatment

  • LY-2409881

  • SU-9516

  • DMSO

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved